MANTEIA
DEAD

Serial Number

76458853

Owner

ARES TRADING S.A.

Attorney

Robert B.G. Horowitz, Esq.

Filing Date

Oct 7, 2002

Add to watchlist:

No watchlists yet
View on USPTO

MANTEIA Trademark

Serial Number: 76458853 • Registration: 2930025

MANTEIA is a trademark filed by ARES TRADING S.A. on October 7, 2002. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

ARES TRADING S.A. (353 trademarks)

CHATEAU DE VAUMARCUS

Entity Type: 03

Manteia S.A.

Zone Industrielle
Coinsins CH-1267 , CH

Entity Type: 03

Trademark Details

Filing Date

October 7, 2002

Registration Date

March 8, 2005

Published for Opposition

December 14, 2004

Cancellation Date

September 21, 2012

Goods & Services

MAGNETIC AND OPTICAL DATA CARRIERS PRE-RECORDED WITH MEDICAL AND GENETIC INFORMATION FOR USE IN MEDICAL APPLICATIONS; COMPUTER SOFTWARE FOR CONTROLLING DATA FROM MEDICAL EQUIPMENT RELATING TO GENETIC, DIAGNOSTIC AND THERAPEUTIC APPLICATIONS; SEQUENCERS FOR DETERMINING THE NUCLEAC ACID CONTENT OF BIOLOGICAL SAMPLES; COMPUTER SOFTWARE FOR DISPLAYING GRAPHS IN GENOMIC RESEARCH, GENETIC ASSOCIATION STUDIES AND PRODUCT DEVELOPMENT

PHARMACEUTICAL PREPARATIONS, NAMELY, PREPARATIONS FOR THE TREATMENT OF HEMATOLOGICAL DISORDERS, PREPARATIONS FOR THE TREATMENT OF IMMUNOLOGICAL DISEASES AND DISORDERS, PREPARATIONS FOR THE TREATMENT OF INFLAMMATORY DISEASES AND DISORDERS, PREPARATIONS FOR THE TREATMENT OF NECROLOGICAL AND DISORDERS, PREPARATIONS FOR THE TREATMENT OF NEUROLOGICAL AND CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS, PREPARATIONS FOR THE TREATMENT OF REPRODUCTIVE HEALTH DISEASES AND DISORDERS, PREPARATIONS FOR THE TREATMENT OF ENDOCRINOLOGY DISEASES AND DISORDERS, PREPARATIONS FOR THE TREATMENT OF AUTOIMMUNE DISEASES AND DISORDERS, PREPARATIONS FOR THE TREATMENT OF DISEASES AND DISORDERS ASSOCIATED WITH AGING, PREPARATIONS FOR THE TREATMENT OF NEONATAL RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS; PREPARATIONS FOR THE TREATMENT OF METABOLIC DISEASES AND DISORDERS, PREPARATIONS FOR THE TREATMENT OF DIABETES, PREPARATIONS FOR THE TREATMENT OF CARDIOVASCULAR AND CIRCULATORY DISEASES AND DISORDERS, PREPARATIONS FOR THE TREATMENT OF GASTROENTEROLOGICAL DISEASES AND DISORDERS, PREPARATIONS FOR THE TREATMENT OF GROWTH HORMONE DEFICIENCY DISEASES AND DISORDERS,PREPARATIONS FOR THE TREATMENT OF SKIN DISEASES AND DISORDERS, PREPARATIONS FOR THE TREATMENT OF METABOLIC DISEASES AND DISORDERS, PREPARATIONS FOR THE TREATMENT OF DNA AND/OR RNA (DEOXYRIBONUCLEIC ACID AND RIBONUCLEIC ACID) DISORDERS AND FOR THE TREATMENT OF DISEASES RELATED TO DNA AND/OR RNA DISORDERS

DIAGNOSTIC PRODUCTS, NAMELY, DNA SEQUENCES FOR SCIENTIFIC USE; DIAGNOSTIC TEST KITS FOR SCIENTIFIC USE COMPRISED PRIMARILY OF REAGENTS, PROCESSING CHEMICALS, SLIDES, AND PATCHES

PHARMACEUTICAL ADVICE; HEALTH CARE, MEDICAL ASSISTANCE, NAMELY, DIAGNOSTIC AND PROGNOSTIC ADVICE IN THE SELECTION OF TREATMENT AND IN THE PREVENTIVE AND PREDICTIVE MEDICINE FIELDS; HOSPITALS; BLOOD BANK SERVICES; PLASTIC SURGERY; ARTIFICIAL INSEMINATION SERVICES; IN VITRO FERTILIZATION SERVICES; VETERINARY ASSISTANCE; ANIMAL BREEDING; WEED KILLING

MEDICAL EQUIPMENT, NAMELY, DNA AND RNA ANALYSIS APPARATUS COMPRISING A DEVICE TO EXTRACT NUCLEIC ACIDS FROM BIOLOGICAL SAMPLES, A DEVICE FOR CONVERTING THE NUCLEIC ACIDS TO DNA, A DEVICE FOR SEQUENCING THE ISOLATED DNA, COMPUTER HARDWARE AND COMPUTER SOFTWARE FOR CONTROLLING OR OPERATING THE MEDICAL EQUIPMENT FOR DETERMINING DISEASE PREDISPOSITION AND RESPONSE TO MEDICAL TREATMENT, FOR USE IN GENETIC ASSOCIATION STUDIES, FOR USE IN GENOME MAPPING, FOR USE IN GENOME ANALYSIS, FOR USE IN GENOME SCANNING, FOR USE IN GENE EXPRESSION LEVEL MONITORING, FOR USE IN DETERMINING NUCLEIC ACID COMPOSITION OF BIOLOGICAL SAMPLES, FOR USE IN GENOME SEQUENCING, ALL FOR HUMAN AND VETERINARY MEDICAL PURPOSES; DIAGNOSTIC EQUIPMENT FOR MEDICAL USE, NAMELY, COMPUTERS AND PRINTERS USED FOR THE ANALYSIS, INTERPRETATION AND DISPLAY OF DIAGNOSTIC TESTS AND TEST RESULTS

BIOTECHNOLOGY RESEARCH AND DEVELOPMENT SERVICES FOR OTHERS, NAMELY, GENETIC ASSOCIATION STUDIES, GENOME MAPPING, GENOME ANALYSIS, GENOME SCANNING, GENE EXPRESSION LEVEL MONITORING, NUCLEIC ACID COMPOSITION OF SCANNING, GENE EXPRESSION LEVEL MONITORING, NUCLEIC ACID COMPOSITION OF BIOLOGICAL SAMPLES GENOME SEQUENCING, ECOSYSTEM SEQUENCING, DRUG AND THERAPEUTIC PREPARATIONS DEVELOPMENT, AND CONSULTATION IN THE FIELD OF GENOMICS AND DRUG DEVELOPMENT; SCIENTIFIC RESEARCH IN THE NATURE OF DNA SEQUENCING

Filing History

CANCELLED SEC. 8 (6-YR)
Sep 21, 2012 C8..
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 29, 2009 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 29, 2009 REAP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 23, 2008 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 23, 2008 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 13, 2006 TCCA
REGISTERED-PRINCIPAL REGISTER
Mar 8, 2005 R.PR
PUBLISHED FOR OPPOSITION
Dec 14, 2004 PUBO
NOTICE OF PUBLICATION
Nov 24, 2004 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 6, 2004 PREV
ASSIGNED TO LIE
Oct 1, 2004 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 30, 2004 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 30, 2004 XAEC
EXAMINERS AMENDMENT MAILED
Sep 29, 2004 CNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 28, 2004 CNEA
EXAMINER'S AMENDMENT ENTERED
Aug 29, 2004 XAEC
FINAL REFUSAL MAILED
Jun 28, 2004 CNFR
Sec. 1(B) CLAIM DELETED
May 27, 2004 1.BD
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 27, 2004 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 27, 2004 CRFA
PAPER RECEIVED
May 27, 2004 MAIL
NON-FINAL ACTION MAILED
Nov 26, 2003 CNRT
CASE FILE IN TICRS
Sep 25, 2003 CFIT
PAPER RECEIVED
Aug 25, 2003 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 20, 2003 CRFA
NON-FINAL ACTION MAILED
Feb 25, 2003 CNRT
ASSIGNED TO EXAMINER
Feb 10, 2003 DOCK